HK1256969A1 - Fungal keratitis prophylactic or therapeutic agent - Google Patents
Fungal keratitis prophylactic or therapeutic agent Download PDFInfo
- Publication number
- HK1256969A1 HK1256969A1 HK18116109.4A HK18116109A HK1256969A1 HK 1256969 A1 HK1256969 A1 HK 1256969A1 HK 18116109 A HK18116109 A HK 18116109A HK 1256969 A1 HK1256969 A1 HK 1256969A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- rapamycin
- polyethylene glycol
- agent
- salt
- keratomycosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562220847P | 2015-09-18 | 2015-09-18 | |
| US201562220847P | 2015-09-18 | ||
| PCT/JP2016/077014 WO2017047597A1 (ja) | 2015-09-18 | 2016-09-13 | 角膜真菌症の予防または治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1256969A1 true HK1256969A1 (en) | 2019-10-04 |
Family
ID=58288799
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18116109.4A HK1256969A1 (en) | 2015-09-18 | 2016-09-13 | Fungal keratitis prophylactic or therapeutic agent |
| HK18112748.0A HK1253545A1 (zh) | 2015-09-18 | 2016-09-13 | 角膜真菌病的预防或治疗剂 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK18112748.0A HK1253545A1 (zh) | 2015-09-18 | 2016-09-13 | 角膜真菌病的预防或治疗剂 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US10166217B2 (https=) |
| EP (1) | EP3351244A4 (https=) |
| JP (1) | JP6639364B2 (https=) |
| KR (1) | KR20180053340A (https=) |
| CN (1) | CN108025000A (https=) |
| BR (1) | BR112018005305A2 (https=) |
| HK (2) | HK1256969A1 (https=) |
| MX (1) | MX393608B (https=) |
| MY (1) | MY183906A (https=) |
| PH (1) | PH12018500579A1 (https=) |
| SG (1) | SG11201802091RA (https=) |
| TW (1) | TWI721015B (https=) |
| WO (1) | WO2017047597A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112957321B (zh) * | 2021-03-04 | 2022-08-05 | 青岛大学附属医院 | 一种氧化硫酸软骨素改性的那他霉素滴眼液及其制备方法 |
| CN114568490B (zh) * | 2022-04-01 | 2023-12-19 | 眉山职业技术学院(眉山技师学院) | 雷帕霉素在抑制柑橘青霉菌生长中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4974903B2 (ja) | 2005-02-09 | 2012-07-11 | 参天製薬株式会社 | 疾患または状態を処置するための液体処方物 |
| CN101137369A (zh) * | 2005-02-09 | 2008-03-05 | 马库赛特公司 | 用于眼治疗的制剂 |
| PL2001466T3 (pl) | 2006-03-23 | 2016-06-30 | Santen Pharmaceutical Co Ltd | Rapamycyna w małej dawce do leczenia chorób związanych z przepuszczalnością naczyń |
| WO2009023877A2 (en) * | 2007-08-16 | 2009-02-19 | Macusight, Inc. | Formulations for treatment of ocular diseases or conditions |
-
2016
- 2016-09-13 JP JP2016178997A patent/JP6639364B2/ja not_active Expired - Fee Related
- 2016-09-13 CN CN201680054195.5A patent/CN108025000A/zh active Pending
- 2016-09-13 HK HK18116109.4A patent/HK1256969A1/en unknown
- 2016-09-13 MY MYPI2018000383A patent/MY183906A/en unknown
- 2016-09-13 TW TW105129822A patent/TWI721015B/zh not_active IP Right Cessation
- 2016-09-13 BR BR112018005305-8A patent/BR112018005305A2/pt not_active Application Discontinuation
- 2016-09-13 HK HK18112748.0A patent/HK1253545A1/zh unknown
- 2016-09-13 US US15/760,210 patent/US10166217B2/en active Active
- 2016-09-13 SG SG11201802091RA patent/SG11201802091RA/en unknown
- 2016-09-13 MX MX2018003381A patent/MX393608B/es unknown
- 2016-09-13 KR KR1020187010106A patent/KR20180053340A/ko not_active Withdrawn
- 2016-09-13 EP EP16846468.3A patent/EP3351244A4/en not_active Withdrawn
- 2016-09-13 WO PCT/JP2016/077014 patent/WO2017047597A1/ja not_active Ceased
-
2018
- 2018-03-16 PH PH12018500579A patent/PH12018500579A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20180053340A (ko) | 2018-05-21 |
| CN108025000A (zh) | 2018-05-11 |
| SG11201802091RA (en) | 2018-04-27 |
| MY183906A (en) | 2021-03-17 |
| BR112018005305A2 (pt) | 2018-10-09 |
| MX393608B (es) | 2025-03-24 |
| US10166217B2 (en) | 2019-01-01 |
| HK1253545A1 (zh) | 2019-06-21 |
| TW201717943A (zh) | 2017-06-01 |
| PH12018500579A1 (en) | 2018-09-10 |
| US20180271841A1 (en) | 2018-09-27 |
| JP2017057199A (ja) | 2017-03-23 |
| JP6639364B2 (ja) | 2020-02-05 |
| TWI721015B (zh) | 2021-03-11 |
| WO2017047597A1 (ja) | 2017-03-23 |
| MX2018003381A (es) | 2018-08-15 |
| EP3351244A1 (en) | 2018-07-25 |
| EP3351244A4 (en) | 2019-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220184075A1 (en) | Pharmaceutical composition containing hdac6 inhibitor as active ingredient for prevention or treatment of itching | |
| US11612590B2 (en) | Therapeutic agent for meibomian dysfunction | |
| JPWO2016072440A1 (ja) | 眼科用水性組成物 | |
| AU2024227501A1 (en) | Antifungal agents with enhanced activity in acidic pH | |
| US10166217B2 (en) | Fungal keratitis prophylactic or therapeutic agent | |
| WO2016171152A1 (ja) | 角膜障害の治療剤、改善剤または予防剤 | |
| TW201518291A (zh) | 含聚乙二醇之組成物 | |
| EP3242554A1 (en) | Concise synthesis of urea derivatives of amphotericin b | |
| EP3733179A1 (en) | Pharmaceutical preparation containing pyridyl aminoacetic acid compound | |
| KR102034243B1 (ko) | 에피디티오디옥소피페라진 화합물 또는 이의 유도체, 또는 이들의 약학적으로 허용가능한 염을 포함하는 폐동맥고혈압 예방 또는 치료용 약학적 조성물 | |
| WO2016196989A1 (en) | Topical composition | |
| CN108348516B (zh) | 外用剂 | |
| CA2979802C (en) | Pharmaceutical composition comprising polypeptide | |
| JP4239036B2 (ja) | 改良薬剤組成物 | |
| AU2020411442A1 (en) | Aqueous suspension composition containing sirolimus or salt thereof | |
| MXPA02003833A (es) | Un metodo para tratamiento de tumores con derivados de fumagillol. | |
| WO2018117211A1 (ja) | 眼疾患の治療及び／又は予防剤 | |
| HK1243347B (en) | Pharmaceutical composition comprising polypeptide | |
| JPH10503202A (ja) | アザスピラン類を用いる日和見感染の治療方法 | |
| HK1238174A1 (en) | Ophthalmic aqueous composition | |
| HK1235711A1 (en) | Ophthalmic aqueous composition |